Prospective observational study to assess the effect of extrafine fixed triple therapy on symptom control and adherence to treatment in patients with moderate or severe COPD in routine clinical practice conditions (TRIATH Study
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: CHIESI ESPAÑA, SA
- Execution start: 25/06/2021
- End of execution: 28/02/2023
- IP: CONCEPTION MORALES GARCIA